期刊文献+

重组大肠杆菌不耐热肠毒素B亚单位表达条件的优化及其佐剂作用 被引量:2

Optimization of Condition for Expression of Recombinant E.coli Heat-labile Enterotoxin B Subunit and Adjuvanticity of Expressed Product
下载PDF
导出
摘要 目的优化重组大肠杆菌不耐热肠毒素B亚单位(LTB)的表达条件,并检测其黏膜佐剂作用。方法通过向LB培养基中添加葡萄糖(终浓度为0.5%)、低温培养诱导等方法诱导LTB的表达;采用阳离子交换法对目的蛋白进行纯化;以LTB作为佐剂进行免疫试验。结果可溶性重组大肠杆菌不耐热肠毒素(LTB)的表达量明显提高,纯化后蛋白含量达95%以上,经纯化的LTB作为三价流感裂解疫苗或gD抗原的佐剂免疫BALB/c小鼠,可提高小鼠血清及黏膜的抗体水平,且其效果与铝化剂及福氏佐剂相当或更高。结论优化了LTB的表达条件,且表达的LTB具有较强的黏膜免疫佐剂作用。 Objective To optimize the condition for expression of recombinant E. coli heat-labile enterotoxin B subunit (LTB) and determine the adjuvanticity of expressed product.Methods Optimize the condition for expression of rercombinantE, coli LTB by addition of glucose to LB medium to a final concentration of 0.5 % and induction at low temperature. Purify the expressed LTB by cation exchange chromatography. Immunize BALB/c mice with split influenza virus vaccine using LTB as adjuvant and determine the antibody level induced. Results After the condition for expression was optimized, the expression level of LTB increased significantly. The protein content of LTB after purification reached more than 95% .The serum and mucosal antibody levels of mice immunized with split influenza virus vaccine containing LTB as adjuvant were equivalent to even higher those containing aluminum or Freund adjuvant. Conclusion The condition for expression of recombi- nant E. coli LTB was successfully optimized, and the expressed LTB showed good adjuvanticity to mucosal immunization.
出处 《中国生物制品学杂志》 CAS CSCD 2008年第3期174-177,共4页 Chinese Journal of Biologicals
基金 甘肃省自然基金资助项目(3ZS051-A25-094)
关键词 大肠杆菌不耐热肠毒素B亚单位 黏膜免疫 表达 纯化 佐剂 E. coil heat-labile enterotoxin B subunit Mucosal immunization Expression Purification Adjuvanticity
  • 相关文献

参考文献11

  • 1Gyles CL. Escherichia coli cytotoxins and enterotoxins. Can J Microbiol, 1992,38(7) :734-746.
  • 2Dallas WS, Falkow S. Amino acid sequence homology between cholera toxin and Escherichia coli heat-labile toxin. Nature, 1980,288(5790): 499-501.
  • 3Eun JP,Ji HC, Jang SK, et al. The mucosal adjuvanticity of two nontoxic mutanls of Escherichia coli heat-labile enterotoxin varies with immunization routes. Exp Molecular Med,2000,32(2):72-78.
  • 4Richard W, Bruno G, Weltzin R, et al. Parenteral adjuvantaetivlties of coli heat-labile toxin and its B subunit for Immunization of mice against gastric Helicobacter priori infection.Infect Immun,2000,68 (5):2775-2782.
  • 5Ogra PL, Fadea H, Welliver RC. Vaccination strategies for mucosal immune responses. Clin Micro Rev,2O01,14(2):430-445.
  • 6郭红,邹全明,赵哓晏,吴超.幽门螺杆菌HspA与大肠杆菌LTB基因融合及表达[J].世界华人消化杂志,2003,11(10):1475-1479. 被引量:2
  • 7黄思扬,马超,雷清,蒋琳,沈心亮,王锐.大肠杆菌不耐热肠毒素B亚单位的克隆、表达及初步纯化[J].生物技术,2005,15(6):17-20. 被引量:3
  • 8李忠明,主编.当代新疫苗.北京:高等教育出版社,2000.170-181.
  • 9Haan L, Verweij WR, Holtrop M,et al. Nasal or intramuscular immunization of mice with influenza subunit antigen and the B subunit of Escherichia coli heat-labile toxin induce sIgA-or IgG-mediatedprotec tive mucosal immunity. Vaccine, 2001,19(20-22) : 2898-2907.
  • 10Pizza M, Giuliani MM,Fontana MR, et al. Mucosal caccines:non toxic derivatives of LT and CT as mucosal adjuvants. Vaccine,2001,19( 17, 19) :2534-2541.

二级参考文献82

  • 1Gotteland M, Corvalan A, Sarmiento F, Chavez E, Backouse C,Palma M, Kakarieka E, Vial MT, Figueroa G. Gastric permeability is not increased in children colonized by CagA-positive strains of Helicobacter pylori. Did Liver Dis 2001;33:750-754.
  • 2Dundon WG, Nishioka H, Polenghi A, Papinutto E, Zanotti G, Montemurro P, Del GG, Rappuoli R, Montecucco C.The neutrophil-activating protein of Helicobacter pylori. Int J Med Microbiol 2002;291:545-550.
  • 3Londono-Arcila P, Freeman D, Kleanthous H, O'Dowd AM,Lewis S, Turner AK, Rees EL, Tibbitts TJ, Greenwood J, Monath TP, Darsley MJ. Attenuated salmonella enterica serovar Typhi expressing urease effectively immunizes mice against Helicobacter pylori challenge as part of a heterologous mucosal priming parenteral boosting vaccination regimen. Infect Immun 2002;70:5096-5106.
  • 4Raghavan S, Svennerholm AM, Holmgren J. Effects of oral vaccination and immunomodulation by cholera toxin on experimental Helicobacter pylori infection, reinfection, and gastritis.Infect Immun 2002;70:4621-4627.
  • 5Keller WC, Michetti P. Vaccination against Helicobacter pylorian old companion of man. Expert Opin Biol Ther 2001;1:795-802.
  • 6Nilsson CL. Bacterial proteomics and vaccine development.Am J Pharmacogenomics 2002;2:59-65.
  • 7Figura N, Piomboni P, Ponzetto A, Gambera L, Lenzi C, Vaira D, Peris C, Lotano MR, Gennari L, Bianciardi L, Renieri T,Valensin PE, Capitani S, Moretti E, Colapinto R, Baccetti B,Gennari C. Helicobacter pylori infection and infertility. Eur J Gastroenterol Hepatol 2002;14:663-669.
  • 8De Haan L, Verweij WR, Feil IK, Holtrop M, Hol WG, Agsteribbe E, Wilschut J. Role of GM1 binding in the mucosal immunogenicity and adjuvant activity of the Escherichia coli heat-labile enterotoxin and its B subunit. Immunology 1998;94:424-430.
  • 9Weltzin R, Guy B, Thomas WD Jr, Giannasca PJ, Monath TP.Parenteral adjuvant activities of Escherichia coli heat-labile toxin and its B subunit for immunization of mice against gastric Helicobacter pylori infection. Infect Immun 2000;68:2775-2782.
  • 10Go MF. Review article: natural history and epidemiology of Helicobacter pylori infection. Aliment Pharmacol Ther 2002;16(Suppl 1): 3-15.

共引文献11

同被引文献20

  • 1刘汉清,武力,李美娣,王甜,苏胖.大肠杆菌不耐热肠毒素B亚基表达系统的研究进展[J].中国预防兽医学报,2021,43(3):333-338. 被引量:2
  • 2Vasserman Y, Pitcovski J. Genetic detoxification and adjuvant-attivity retention of Escherichia coli enterotoxin LT [J].Avian Pathol. 2006, 35 (2): 134-140.
  • 3Yamanaka H, Ishibashi D, Yamaguchi N, et al. Enhanced mucosal immunogenieity of priori protein following fusion with B subunit of Escherichia coli heat-labile enterotoxin [J]. Vaccine, 2006, 24 ( 15): 2815-2823.
  • 4Alone. PV, Garg LC. Secretory and GMI receptor binding role of N-terminal region of LTB in Vibrio cholerae [J]. Biochem Biophys Res Commun, 2008, 376 (4) : 770-774.
  • 5Zhang GG, Li DX, Zhang HH, et al. Enhancement of mueosal immune response against the M2eHBc+ antigen in mice with the fusion expression products of LTB and M2eHBc+ through mucosal immunization route [J]. Vet Res Commun, 2009, 33 (7): 735- 747.
  • 6Liang S, Hosur KB, Nawar HF, et al. In vivo and in vitro adjuvant activities of the B subunit of type IIb heat-labile enterotoxin (LT-IIb-B5) from Escherichia coli [J].Vaccine, 2009, 27 (32): 4302-4308.
  • 7Ma X. Sao B, Zheng W, et al. Ccmaparative study on eharacteri-zation of recombinant B subunit of E. coli heat-labile enterotoxin(rLTB) prepared from E. coil and P. patoris [J]. J Microbiol Biotechnol, 2010, 20 ( 3 ) : 550-557.
  • 8Moravec T. Schmidt MA, Herman EM, et al. Production of Escheriehia coil heat labile toxin (LT) B sulmnit in soybean seed and analysis of its imnmnogenicity as an oral vaccine[J]. Vaccine, 2007, 25 (9): 1647-1657.
  • 9Svennerhohn AM. From cholera to enteroloxigenic Escherichia coil (ETEC) vaccine development [J]. Indian J Med Res, 2011, 133 (2): 188-196.
  • 10Lira JG, Kim JA, Chung HJ, et al. Expression of functional pentameric heat-labile enterotoxin B subunit of Escherichia coli in Saccharomyces cerevisiae [J]. J Microbiol Biotechnol, 2009, 19 (5): 502-510.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部